Long-term clinical outcomes of peritoneal dialysis patients: Single center experience from Korea

Peritoneal Dialysis International

Volumn 28, Issue SUPP. 3, 2008, Pages

  Han, Seung Hyeok ^a   Lee, Jung Eun ^a   Kim, Dong Ki ^a   Moon, Sung Jin ^a   Kim, Hyun Wook ^a   Chang, Jae Hyun ^a   Kim, Beom Seok ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Lee, Ho Yung ^a   Han, Dae Suk ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b NONE   (South Korea)

Author keywords

Continuous ambulatory peritoneal dialysis; Patient survival; Technique survival

Indexed keywords

ADULT; CARDIOVASCULAR DISEASE; COMORBIDITY; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; KOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT RESPONSE; TREND STUDY;

ADULT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KOREA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RISK FACTORS; SURVIVAL RATE;

EID: 48749116572     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20:2587-93.
2. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34:1065-74.
3. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006; 103:S3-11.
4. Han DS, Hwang JH, Kang DH, Song HY, Noh H, Shin SK, et al. Current status of peritoneal dialysis in Korea: efforts to achieve optimal outcome. Perit Dial Int 1999; 19(Suppl 3):S17-25.
5. Chung SH, Chu WS, Lee HA, Kim YH, Lee TS, Lindholm B, et al. Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000; 20:541-7.
6. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, et al. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int 2007; 27:432-40.
7. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JG, Stevens P, et al. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int 1999; 55:1476-85.
8. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
9. Mujais S, Story K. Peritoneal dialysis in the U.S.: evaluation of outcomes in contemporary cohorts. Kidney Int Suppl 2006; 103:S21-6.
10. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis 2007; 49:A6-7, S1-296.
11. Shinzato T, Nakai S, Akiba T, Yamagami S, Yamazaki C, Kitaoka T, et al. Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int 1999; 55:700-12.
12. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2:642-4.
13. Canadian CAPO Clinical Trials Group. Peritonitis in continuous ambulatory peritonealdialysis (CAPD): a multicentre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 1989; 9:159-63.
14. Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LY, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999; 55:2515-23.
15. Hemmelgarn BR, Chou S, Wiebe N, Culleton BF, Manns BJ, Klarenbach S, et al. Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in Canada. Am J Kidney Dis 2006; 48:964-71.
16. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14:3270-7.
17. Lee HB, Chung SH, Chu WS, Kim JK, Ha H. Peritoneal dialysis in diabetic patients. Am J Kidney Dis 2001; 38(Suppl 1):5200-3.
18. Lee HY, Choi HY, Park HE, Seo BJ, Do JY, Yun SR, et al. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 2006; 21:2893-9.
19. Chung SH, Stenvinkel P, Bergström J, Undholm B. Biocompatibility of new peritoneal dialysis solutions: what can we hope to achieve? Perit Dial Int 2000; 20(Suppl 5):S57-67.
20. Huisman RM, Nieuwenhuizen MG, Th de Charro F. Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in the Netherlands. Nephrol Dial Transplant 2002; 17:1655-60.